SUZHOU, China and ROCKVILLE, Md., Jan. 10, 2024 /PRNewswire/ — Ascentage Pharma (6855.HK), a commercial stage global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that Dr. Dajun Yang, the company’s Chairman and CEO, gave a speech at the 42nd Annual J.P. Morgan Healthcare Conference.… Continue reading Ascentage Pharma Presented at 42nd Annual J.P. Morgan Healthcare Conference
Tag: Morgan
Celltrion presents strategic vision and growth plan at the 42nd Annual J.P. Morgan Healthcare Conference
Celltrion looks beyond biosimilars to bring value to healthcare and to pioneer innovation Company outlines key business strategies, including expanded product pipeline and healthcare intelligence bank, building upon groundbreaking legacy of success in biosimilars Company highlights its target of 22 products by 2030 and projects five-fold growth INCHEON, South Korea, Jan. 10, 2024 /PRNewswire/ — Celltrion,… Continue reading Celltrion presents strategic vision and growth plan at the 42nd Annual J.P. Morgan Healthcare Conference
SOPHiA GENETICS Highlights Near-Term Growth Strategy at 42nd Annual J.P. Morgan Healthcare Conference
Strong SOPHiA DDM™ adoption and analysis volume contributes to continued revenue growth Liquid biopsy and HRD on SOPHiA DDM™ Platform continue to grow year-over-year, with Tennessee Oncology, Dasa and The Royal Marsden announced today BOSTON and ROLLE, Switzerland, Jan. 10, 2024 /PRNewswire/ — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in… Continue reading SOPHiA GENETICS Highlights Near-Term Growth Strategy at 42nd Annual J.P. Morgan Healthcare Conference
HANZA invests in new factory in Sweden
HANZA AB is investing SEK 75 million in an expansion of the Group’s manufacturing cluster in Sweden to meet increasing volumes. KISTA, Sweden, Jan. 10, 2024 /PRNewswire/ — HANZA has decided to build a new factory section of 8,800 square meters in Töcksfors, Sweden. The new facility is a new and extension of HANZA’s existing… Continue reading HANZA invests in new factory in Sweden
Samsung Biologics presents 2024 business plans at J.P. Morgan Healthcare Conference
INCHEON, South Korea, Jan. 9, 2024 /PRNewswire/ — Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today presented its 2024 business plans and strategy at the J.P. Morgan Healthcare Conference held in San Francisco, California. During the main track presentation, John Rim, CEO and President of Samsung Biologics, announced that the… Continue reading Samsung Biologics presents 2024 business plans at J.P. Morgan Healthcare Conference
LOTTE BIOLOGICS Announces Songdo Bio Plant Development Plan at JPM Healthcare Conference 2024
Richard Lee, CEO of LOTTE BIOLOGICS, delivers a keynote speech at the JPM Healthcare Conference for the second consecutive year Unveils company’s bio plant development plan in Songdo to meet clients’ needs SEOUL, South Korea, Jan. 9, 2024 /PRNewswire/ — LOTTE BIOLOGICS (CEO Richard Lee) announced its participation as a participating presenter on the Asia Pacific &… Continue reading LOTTE BIOLOGICS Announces Songdo Bio Plant Development Plan at JPM Healthcare Conference 2024
BRIXMOR PROPERTY GROUP PRICES OFFERING OF SENIOR NOTES
NEW YORK, Jan. 9, 2024 /PRNewswire/ — Brixmor Property Group Inc. (NYSE: BRX) (“Brixmor” or the “Company”) announced today that its operating partnership, Brixmor Operating Partnership LP (the “Operating Partnership”), priced an offering of $400 million aggregate principal amount of 5.500% Senior Notes due 2034 (the “Notes”). The Notes will be issued at 99.816% of par… Continue reading BRIXMOR PROPERTY GROUP PRICES OFFERING OF SENIOR NOTES
CME Group to Launch Options on S&P 500 Annual Dividend Index Futures on January 29
CHICAGO, Jan. 9, 2024 /PRNewswire/ — CME Group, the world’s leading derivatives marketplace, today announced it will launch options on S&P 500 Annual Dividend Index futures on January 29, pending regulatory review. “Client demand for managing risk and seeking investment opportunities around dividend exposure has accelerated the growth of our listed and centrally cleared dividend… Continue reading CME Group to Launch Options on S&P 500 Annual Dividend Index Futures on January 29
L.E.K. Consulting Announces 11 New Global Partner Promotions
BOSTON and LONDON, Jan 9, 2024 /PRNewswire/ — Global strategy consultancy L.E.K. Consulting has elected 11 new partners. The promotions recognize the significant expertise and insights that these leaders bring to bear for clients across multiple industry sectors and geographies who are facing critical decisions. “We are pleased to announce the newest partner appointments at… Continue reading L.E.K. Consulting Announces 11 New Global Partner Promotions
Bairong Inc. Founder & CEO Presents at the Morgan Stanley China New Economy Summit
BEIJING, Jan. 8, 2024 /PRNewswire/ — On January 5, 2024, Bairong Inc. (“Bairong” or the “Company”; HKEX: 6608) participated in the Morgan Stanley China New Economy Summit. Mr. Felix Zhang, the founder and CEO of the company, presented at the AI panel. Continue Reading Bairong Inc. Founder & CEO Presents at the Morgan Stanley China… Continue reading Bairong Inc. Founder & CEO Presents at the Morgan Stanley China New Economy Summit